Stock Price
32.46
Daily Change
0.03 0.09%
Monthly
15.97%
Yearly
11.62%
Q3 Forecast
32.16

Veracyte reported $115.85M in Operating Expenses for its fiscal quarter ending in June of 2025.




Operating Expenses Change Date
Agilent USD 1.38B 10M Jul/2025
Arrowhead Research USD 193.32M 31.81M Jun/2025
Bruker USD 785.5M 15.9M Jun/2025
Exact Sciences USD 813.23M 10.44M Jun/2025
Illumina USD 845M 65M Jun/2025
Laboratory Of America USD 3.06B 51.8M Jun/2025
Ligand Pharmaceuticals USD 40.46M 41.09M Jun/2025
Myriad Genetics USD 224.9M 24.7M Mar/2025
Roche Holding CHF 11.43B 1.48B Dec/2024
Siemens EUR 16.62B 469M Jun/2025
Sonic Healthcare AUD 4.23B 2.14B Dec/2024
Thermo Fisher Scientific USD 8.94B 291M Jun/2025
Veracyte USD 115.85M 2.54M Jun/2025
Waters USD 583.12M 73.16M Jun/2025